Goal-directed therapy: what we know and what we need to know

Goal-directed therapy (GDT) utilizes monitoring techniques to help guide clinicians with administering fluids, vasopressors, inotropes, or other treatments to patients in various clinical settings. Multiple studies have investigated the potential benefits of GDT, but no consensus on the use of GDT e...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neal, Jason B, Shaw, Andrew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328058/
https://www.ncbi.nlm.nih.gov/pubmed/25685329
http://dx.doi.org/10.1186/s13741-015-0012-1
_version_ 1782357177000787968
author O’Neal, Jason B
Shaw, Andrew D
author_facet O’Neal, Jason B
Shaw, Andrew D
author_sort O’Neal, Jason B
collection PubMed
description Goal-directed therapy (GDT) utilizes monitoring techniques to help guide clinicians with administering fluids, vasopressors, inotropes, or other treatments to patients in various clinical settings. Multiple studies have investigated the potential benefits of GDT, but no consensus on the use of GDT exists. Future trials which address fluid and inotrope choice as well as expanding the results to evaluate patient-centered outcomes in addition to survival are warranted.
format Online
Article
Text
id pubmed-4328058
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43280582015-02-15 Goal-directed therapy: what we know and what we need to know O’Neal, Jason B Shaw, Andrew D Perioper Med (Lond) Editorial Goal-directed therapy (GDT) utilizes monitoring techniques to help guide clinicians with administering fluids, vasopressors, inotropes, or other treatments to patients in various clinical settings. Multiple studies have investigated the potential benefits of GDT, but no consensus on the use of GDT exists. Future trials which address fluid and inotrope choice as well as expanding the results to evaluate patient-centered outcomes in addition to survival are warranted. BioMed Central 2015-02-05 /pmc/articles/PMC4328058/ /pubmed/25685329 http://dx.doi.org/10.1186/s13741-015-0012-1 Text en © O'Neal and Shaw; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Editorial
O’Neal, Jason B
Shaw, Andrew D
Goal-directed therapy: what we know and what we need to know
title Goal-directed therapy: what we know and what we need to know
title_full Goal-directed therapy: what we know and what we need to know
title_fullStr Goal-directed therapy: what we know and what we need to know
title_full_unstemmed Goal-directed therapy: what we know and what we need to know
title_short Goal-directed therapy: what we know and what we need to know
title_sort goal-directed therapy: what we know and what we need to know
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328058/
https://www.ncbi.nlm.nih.gov/pubmed/25685329
http://dx.doi.org/10.1186/s13741-015-0012-1
work_keys_str_mv AT onealjasonb goaldirectedtherapywhatweknowandwhatweneedtoknow
AT shawandrewd goaldirectedtherapywhatweknowandwhatweneedtoknow

Ejemplares similares